A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published ...

One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID. Long ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

It's unclear whether the small increased risks of type 2 diabetes highlighted in this red-meat research hold any true ...

While Alzheimer’s is commonly linked to aging, as per a study young people with diabetes may also face a higher risk due to ...

Researchers discovered that IBD significantly increases the risk of developing T1D, and this association works both ways, ...

Replacing 10 percent of ultra-processed foods with healthier alternatives lowered diabetes risk by up to 18 percent, a new study says.

In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...